Search Results - Yu. V. Lukina
- Showing 1 - 20 results of 115
- Go to Next Page
-
1
RESULTS OF THE CONTROL RANDOMIZED STUDIES IN 2009: WHAT IS NEW IN CARDIOLOGY by S. Yu. Martsevich, Yu. V. Lukina
Published 2016-01-01Results of the control randomized studies in 2009: what is new in cardiology.
Get full text
Article -
2
POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY by Yu. V. Lukina, S. Yu. Martsevich
Published 2016-01-01Data of evidence based cardiology including results of international clinical trials on efficacy and safety of the modern calcium channel blocker (CCB), lercanidipine, are presented. Results of these trials show the firm position of lercanidipine in the modern cardiology and confirm that treatment w...
Get full text
Article -
3
CONGRESS OF THE AMERICAN COLLEGE OF CARDIOLOGY 2010: CRISIS OF CLINICAL GUIDELINES by S. Yu. Martsevich, Yu. V. Lukina
Published 2016-01-01Congress of the American College of Cardiology 2010: crisis of clinical guidelines.
Get full text
Article -
4
COMBINATION THERAPY OF HYPERTENSION — A RELIABLE WAY TO TARGET ACHIEVE by Yu. V. Lukina, S. Yu. Martsevich
Published 2016-01-01Data of evidence-based cardiology and clinical guidelines that define the position of combined therapy to achieve the targets of hypertension (HT) treatment (achievement and maintenance of the target blood pressure (BP) level, protection of the target organs, improvement of the quality of life in hy...
Get full text
Article -
5
THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE by Yu. V. Lukina, S. Yu. Martsevich
Published 2016-01-01Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure, rhythm disorders) are presented. Implementation of bisoprolol generics as well as bisoprolol usage in smoking cardiovascular...
Get full text
Article -
6
NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS by S. Yu. Martsevich, Yu. V. Lukina
Published 2016-01-01The main objectives and strategies for treatment of atrial fibrillation (AF), one of the most common cardiac arrhythmia, are seen. A combination of strategies for heart rate control in patients with atrial fibrillation receiving rhythm-controling therapy is preferred at present, according to current...
Get full text
Article -
7
VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? by Yu. V. Lukina, S. Yu. Martsevich
Published 2015-09-01The problem of varenicline use in patients with cardiovascular diseases is discussed. Results of large clinical trials and meta-analyses with varenicline have proven its high efficacy for treatment of nicotine addiction in adults and a small number of side events. Varenicline is the main agent for p...
Get full text
Article -
8
Beta-adrenoblocker in heart failure: bisoprolol role by Yu. V. Lukina, S. Yu. Martsevich
Published 1970-01-01Main principles of chronic heart failure (CHF) management are presented, including the role of beta-adrenoblockers (BB), in particular, bisoprolol. BB potential as initial CHF treatment is discussed.
Get full text
Article -
9
Effective blood pressure control in arterial hypertension patients: the role of combined fixed-dose pharmaceutical therapy by S. Yu. Martsevich, Yu. V. Lukina, N. S. Oganisyan
Published 2006-08-01Arterial hypertension (AH) is reviewed as the leading cause of cardiovascular disease mortality. The authors stress target blood pressure level achievement as the crucial factor in effective prevention of AH complications. Typically, the latter is possible only with combined pharmaceutical therapy....
Get full text
Article -
10
Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) by S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
Published 2020-11-01Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients with high and very high cardiovascular risk (CVR) in real clinical practice based on the data of the study PRIORITY.Material and methods. The PRIORITY study included 298 patients with high (29; 9.7%) and v...
Get full text
Article -
11
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS by M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich
Published 2015-09-01Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and methods. Patients (n=31, 7 men and 24 women) wit...
Get full text
Article -
12
ORIENTIR Study: design and results by S. Yu. Martsevich, Yu. V. Lukina, I. B. Bondareva
Published 2011-06-01The paper summarizes the specific features of post-marketing studies, which are performed after the medication registration, in the settings close to the real-world clinical practice. In particular, the authors discuss the design and results of the Russian post-marketing study of nifedipine CR (cont...
Get full text
Article -
13
SYSTEMATIC REVIEW AND META-ANALYSIS: PITFALLS OF METHODS by Yu. V. Lukina, S. Yu. Martsevich, N. P. Kutishenko
Published 2016-05-01Methods that allow to systematize the accumulated information on specifically formulated questions, analyze it and make reliable findings are of great interest and popularity with the emergence of a huge number of studies and publications in various fields of medicine, a significant increase in info...
Get full text
Article -
14
THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS by S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
Published 2016-01-01Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases. Beta-blocker indications and safety of their long-term use are considered from this point o...
Get full text
Article -
15
THE PROBLEM OF ADHERENCE TO THE TREATMENT IN MODERN MEDICINE: POSSIBILITIES OF SOLUTION, IMPACT ON THE EFFECTIVENESS OF THERAPY AND DISEASE OUTCOMES by Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich
Published 2017-09-01The problem of adherence remains one of the currently important and at the same time the most difficult one to solve for modern medicine and society. Despite five decades of scientific research on this issue, numerous attempts to create reliable diagnostic tests, the search for methods to increase p...
Get full text
Article -
16
The Moriscos-Green scale: the pros and cons of universal test, correction of mistakes by Yu. V. Lukina, S. Yu. Martsevich, N. P. Kutishenko
Published 2016-03-01One of the most common tests for evaluating of medication adherence – 4-question scale Moriscos-Green – is considered. Advantages (flexibility, conciseness) and disadvantages (insufficient sensitivity and specificity) of this test are presented. Disadvantages of 4-question version of the test were c...
Get full text
Article -
17
ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES by S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko
Published 2017-05-01The role of randomized controlled trials (RCTs) and observational studies in evaluation of the efficacy and safety of drugs in cardiology is discussed. The possibility of using the results of non-interventional studies in accepting the decision to choose the most effective and safe drug is presented...
Get full text
Article -
18
TREATMENT ADHERENCE: MODERN VIEW ON A WELL KNOWN ISSUE by Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich
Published 2017-02-01The treatment adherence problem is one of the most significant for medicine and society. The article focuses on the main aspects of the adherence problem: modern view on terminology of this issue, various factors classification influencing adherence, diagnostics of adherence. A review is pre...
Get full text
Article -
19
Basic principles of combination therapy: focus on drug-drug interaction by S. Yu. Martsevich, Yu. V. Lukina, O. M. Drapkina
Published 2021-11-01The article is devoted to the issue of drug interactions in the combination regimens. Today, when drug therapy is the first-line approach for patients with noncommunicable diseases, and the world population ageing leads to an increase in the number of patients with severe comorbidity and polypharmac...
Get full text
Article -
20
Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies by Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich
Published 2019-11-01Working Group of the NIKEA Study. Yekaterinburg: Akulina E.N., Reznik I.I.; Izhevsk: Grebnev S.A., Yezhov A., Shinkareva S.E.; Krasnodar: Kudryashov E.A., Skibitsky A.V., Skibitsky V.V., Fendrikova A.V.; Krasnoyarsk: Altayev V.D., Matyushin G.V., Nemik D.B., Pitaev R.R., Samokhvalov E.V., Stolbikov...
Get full text
Article